3498 related articles for article (PubMed ID: 7490469)
41. A murine monoclonal antibody, MoAb HMSA-5, against a melanosomal component highly expressed in early stages, and common to normal and neoplastic melanocytes.
Der JE; Dixon WT; Jimbow K; Horikoshi T
Br J Cancer; 1993 Jan; 67(1):47-57. PubMed ID: 7678981
[TBL] [Abstract][Full Text] [Related]
42. A Fluorescent Probe for Early Detection of Melanoma and Its Metastasis by Specifically Imaging Tyrosinase Activity in a Mouse Model.
Zhan C; Cheng J; Li B; Huang S; Zeng F; Wu S
Anal Chem; 2018 Aug; 90(15):8807-8815. PubMed ID: 29975041
[TBL] [Abstract][Full Text] [Related]
43. The 5,6-dihydroxyindole-2-carboxylic acid (DHICA) oxidase activity of human tyrosinase.
Olivares C; Jiménez-Cervantes C; Lozano JA; Solano F; García-Borrón JC
Biochem J; 2001 Feb; 354(Pt 1):131-9. PubMed ID: 11171088
[TBL] [Abstract][Full Text] [Related]
44. Isolation and characterization of variant cDNAs encoding mouse tyrosinase.
Terao M; Tabe L; Garattini E; Sartori D; Studer M; Mintz B
Biochem Biophys Res Commun; 1989 Mar; 159(2):848-53. PubMed ID: 2494997
[TBL] [Abstract][Full Text] [Related]
45. Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
Valmori D; Pittet MJ; Vonarbourg C; Rimoldi D; Liénard D; Speiser D; Dunbar R; Cerundolo V; Cerottini JC; Romero P
Cancer Res; 1999 Aug; 59(16):4050-5. PubMed ID: 10463606
[TBL] [Abstract][Full Text] [Related]
46. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA
J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734
[TBL] [Abstract][Full Text] [Related]
47. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus.
Kwon BS; Haq AK; Pomerantz SH; Halaban R
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7473-7. PubMed ID: 2823263
[TBL] [Abstract][Full Text] [Related]
48. Role of gene expression and protein synthesis of tyrosinase, TRP-1, lamp-1, and CD63 in UVB-induced melanogenesis in human melanomas.
Hara H; Lee MH; Chen H; Luo D; Jimbow K
J Invest Dermatol; 1994 Apr; 102(4):495-500. PubMed ID: 8151127
[TBL] [Abstract][Full Text] [Related]
49. Regulation of tyrosinase in human melanocytes grown in culture.
Halaban R; Pomerantz SH; Marshall S; Lambert DT; Lerner AB
J Cell Biol; 1983 Aug; 97(2):480-8. PubMed ID: 6411733
[TBL] [Abstract][Full Text] [Related]
50. Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice.
Mullins DW; Bullock TN; Colella TA; Robila VV; Engelhard VH
J Immunol; 2001 Nov; 167(9):4853-60. PubMed ID: 11673489
[TBL] [Abstract][Full Text] [Related]
51. Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope.
Wölfel C; Drexler I; Van Pel A; Thres T; Leister N; Herr W; Sutter G; Huber C; Wölfel T
Int J Cancer; 2000 Nov; 88(3):432-8. PubMed ID: 11054673
[TBL] [Abstract][Full Text] [Related]
52. Comparison of two cancer vaccines targeting tyrosinase: plasmid DNA and recombinant alphavirus replicon particles.
Goldberg SM; Bartido SM; Gardner JP; Guevara-Patiño JA; Montgomery SC; Perales MA; Maughan MF; Dempsey J; Donovan GP; Olson WC; Houghton AN; Wolchok JD
Clin Cancer Res; 2005 Nov; 11(22):8114-21. PubMed ID: 16299244
[TBL] [Abstract][Full Text] [Related]
53. Protein kinase C-beta-mediated complex formation between tyrosinase and TRP-1.
Wu H; Park HY
Biochem Biophys Res Commun; 2003 Nov; 311(4):948-53. PubMed ID: 14623273
[TBL] [Abstract][Full Text] [Related]
54. A melanocyte-specific complementary DNA clone whose expression is inducible by melanotropin and isobutylmethyl xanthine.
Kwon BS; Halaban R; Kim GS; Usack L; Pomerantz S; Haq AK
Mol Biol Med; 1987 Dec; 4(6):339-55. PubMed ID: 2449595
[TBL] [Abstract][Full Text] [Related]
55. Molecular basis of mouse Himalayan mutation.
Kwon BS; Halaban R; Chintamaneni C
Biochem Biophys Res Commun; 1989 May; 161(1):252-60. PubMed ID: 2567165
[TBL] [Abstract][Full Text] [Related]
56. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes.
Wölfel T; Van Pel A; Brichard V; Schneider J; Seliger B; Meyer zum Büschenfelde KH; Boon T
Eur J Immunol; 1994 Mar; 24(3):759-64. PubMed ID: 8125142
[TBL] [Abstract][Full Text] [Related]
57. Regulated folding of tyrosinase in the endoplasmic reticulum demonstrates that misfolded full-length proteins are efficient substrates for class I processing and presentation.
Ostankovitch M; Robila V; Engelhard VH
J Immunol; 2005 Mar; 174(5):2544-51. PubMed ID: 15728460
[TBL] [Abstract][Full Text] [Related]
58. Functional conservation of the promoter regions of vertebrate tyrosinase genes.
Sato S; Tanaka M; Miura H; Ikeo K; Gojobori T; Takeuchi T; Yamamoto H
J Investig Dermatol Symp Proc; 2001 Nov; 6(1):10-8. PubMed ID: 11764277
[TBL] [Abstract][Full Text] [Related]
59. Eumelanin biosynthesis is regulated by coordinate expression of tyrosinase and tyrosinase-related protein-1 genes.
Kuzumaki T; Matsuda A; Wakamatsu K; Ito S; Ishikawa K
Exp Cell Res; 1993 Jul; 207(1):33-40. PubMed ID: 7686498
[TBL] [Abstract][Full Text] [Related]
60. New EIA technique for tyrosinase in human melanocytes and its application.
Wakisaka N; Inoue H; Nagase T; Matsuzaki K; Aihara M; Kumagai N
Life Sci; 2000; 66(1):PL1-6. PubMed ID: 10658927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
